Alexandre Speierer

Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas

N. Rodondi, M. Puhan, A. Camerini, 2022, BMC Medicine.

Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria

D. Bauer, N. Rodondi, D. Aujesky, 2022, Journal of the American Heart Association.

The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results

M. Imboden, N. Probst-Hensch, N. Rodondi, 2022, International Journal of Public Health.

Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study

P. Lescuyer, M. Imboden, A. Flahault, 2023, Infection.

Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes—A Cohort Study From Switzerland

M. Imboden, N. Probst-Hensch, N. Rodondi, 2023, International journal of public health.

Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021): a longitudinal study in Switzerland

P. Lescuyer, M. Imboden, A. Flahault, 2023, International Journal for Equity in Health.

Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria

D. Bauer, N. Rodondi, B. Gencer, 2022, Journal of the American Heart Association.